StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
0193.HK$0.21+5.91%
Fair $0.21+0.0%

0193.HK

Capital Estate Limited

Consumer Cyclical / LodgingHKSE

$0.21

+0.01 (+5.91%)

Fairly Valued+0.0%Fair Value $0.21Fund rank 30/100 · Data gapFallback financials|
SA 23/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-140.7M · quality 55.3/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

23/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -1.7%, below the 5% threshold
Thesis & Journal · 0193.HKLocal privado en este navegador · Capital Estate Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$50M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-1.7%

↓

Gross Margin

80.5%

↑

Debt/Equity

0.01

↓
52-Week Range$0
$0$0

TradingView lightweight chart

0193.HK price, volumen y niveles de valoración

Último $0.215Periodo -99.4%
Fair value: $0.215

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-15.1%

FCF CAGR

—

FCF margin

-263.5%

FCF / Net income

10.13x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $53.4M · net income $-13.9M · FCF $-140.7M

2022-FY → 2025-FY

Gross margin

80.5%+20.6% pts

Operating margin

-58.5%-30.7% pts

Net margin

-26.0%+86.6% pts

FCF margin

-263.5%-410.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$53.4M$53.4M$56.4M$36.9M$87.3M
Net Income$-13.9M$-13.9M$5.6M$-30.0M$-98.3M
EBITDA$-634000.00$-634000.00$15.7M$-22.9M$-60.0M
EPS-0.07-0.07—-0.15-0.51
Gross Margin80.5%80.5%75.8%90.3%59.9%
Operating Margin-58.5%-58.5%-47.5%-116.1%-27.8%
Net Margin-26.0%-26.0%9.9%-81.3%-112.6%
Balance Sheet
Debt/Equity0.010.01——0.00
Current Ratio12.1612.16———
Cash Flow
Free Cash Flow$-140.7M$-140.7M$-34.8M$-142.2M$128.4M
Returns
ROE-1.7%-1.7%0.7%-3.7%-11.4%
Valuation
EV/EBITDA——-7.31——
P/B0.060.060.070.050.06
Growth & Yield
Revenue Growth-5.3%-5.3%52.9%-57.7%—
EPS Growth———69.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -12.2%

Total return

-12.2%

Start / end P/E

n/dx → n/dx

EPS bridge

n/d → -0.07

Residual

-12.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-12.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.